Heartland Advisors Inc. raised its holdings in shares of National Research Corporation (NASDAQ:NRC – Free Report) by 374.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 237,147 shares of the company’s stock after acquiring an additional 187,147 shares during the quarter. Heartland Advisors Inc.’s holdings in National Research were worth $4,027,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. M&T Bank Corp lifted its position in shares of National Research by 6.4% in the second quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock worth $229,000 after purchasing an additional 823 shares in the last quarter. Sei Investments Co. increased its stake in National Research by 1.2% in the 3rd quarter. Sei Investments Co. now owns 76,270 shares of the company’s stock valued at $975,000 after buying an additional 900 shares during the last quarter. Russell Investments Group Ltd. increased its stake in National Research by 85.6% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after buying an additional 921 shares during the last quarter. Invesco Ltd. lifted its position in National Research by 6.3% during the 2nd quarter. Invesco Ltd. now owns 17,368 shares of the company’s stock worth $292,000 after buying an additional 1,022 shares in the last quarter. Finally, Alliancebernstein L.P. lifted its position in National Research by 6.3% during the 3rd quarter. Alliancebernstein L.P. now owns 18,499 shares of the company’s stock worth $236,000 after buying an additional 1,100 shares in the last quarter. 47.26% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research firms have recently commented on NRC. Citizens Jmp began coverage on shares of National Research in a research note on Monday, June 22nd. They set a “market outperform” rating and a $23.00 price objective for the company. Weiss Ratings raised National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 29th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $23.00.
National Research Price Performance
Shares of NRC opened at $21.78 on Monday. The company has a market cap of $495.50 million, a price-to-earnings ratio of 55.85 and a beta of 0.35. National Research Corporation has a 1-year low of $11.01 and a 1-year high of $23.00. The company’s fifty day simple moving average is $20.09 and its 200 day simple moving average is $18.20. The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 5.48.
National Research (NASDAQ:NRC – Get Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The company reported $0.21 EPS for the quarter. National Research had a net margin of 6.52% and a return on equity of 122.73%. The firm had revenue of $34.80 million during the quarter.
About National Research
National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.
Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.
Further Reading
- Five stocks we like better than National Research
- Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
- Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet
- Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Corporation (NASDAQ:NRC – Free Report).
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.
